Ligand validation:3DL6

DHF: DIHYDROFOLIC ACID

DHF is a Ligand Of Interest in 3DL6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3DL6_DHF_E_621	37%	35%	0.22	0.917	0.76	1.79	-	6	15	0	100%	1
3DL6_DHF_A_605	19%	34%	0.274	0.869	0.77	1.79	-	6	9	0	100%	1
3DL6_DHF_C_613	17%	34%	0.278	0.856	0.77	1.8	-	6	19	0	100%	1
3DL6_DHF_B_609	6%	35%	0.355	0.787	0.76	1.78	-	6	12	1	100%	1
3DL6_DHF_D_617	2%	35%	0.451	0.688	0.77	1.78	-	6	24	0	100%	1
3DL5_DHF_A_605	54%	31%	0.157	0.922	0.89	1.83	1	9	5	1	100%	1
4EZ8_DHF_A_402	89%	14%	0.09	0.968	1.69	2.19	9	9	0	0	100%	1
1RF7_DHF_A_163	88%	5%	0.065	0.94	2.61	2.79	14	15	0	0	100%	1
6CYV_DHF_A_202	87%	30%	0.073	0.946	0.87	1.88	1	8	0	0	100%	1
6NND_DHF_A_204	84%	7%	0.085	0.948	2.23	2.63	10	12	4	0	100%	1
6MTH_DHF_A_209	78%	34%	0.107	0.948	0.72	1.85	-	6	2	0	100%	0.22

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.